Pyrazoloheteroaryls:: Novel p38α MAP kinase inhibiting scaffolds with oral activity

被引：79

作者：

Revesz, L ^{[1
]}

Blum, E ^{[1
]}

Di Padova, FE ^{[1
]}

Buhl, T ^{[1
]}

Feifel, R ^{[1
]}

Gram, H ^{[1
]}

Hiestand, P ^{[1
]}

Manning, U ^{[1
]}

Neumann, U ^{[1
]}

Rucklin, G ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Global Discovery Chem, CH-4002 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 02期

关键词：

p38; inhibition; MAP kinase inhibition; rheumatoid arthriitis; antiarthritic; anti-inflammatory; collagen-induced arthritis; adjuvant-induced arthritis;

D O I：

10.1016/j.bmcl.2005.10.015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A test library with three novel p38 alpha inhibitory scaffolds and a narrow set of substituents was prepared. Appropriate combination of substituent and scaffold generated potent p38 alpha inhibitors, for example, pyrazolo[3,4-b]pyridine 9, pyrazolo[3,4-d]pyrimidine 18a and pyrazolo[3,4-b]pyrazine 23b with potent in vivo activity upon oral administration in animal models of rheumatoid arthritis. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：262 / 266

页数：5

共 50 条

[1] SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity
Revesz, L
Blum, E
Di Padova, FE
Buhl, T
Feifel, R
Gram, H
Hiestand, P
Manning, U
Rucklin, G
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) : 3601 - 3605
[2] Novel inhibitors of p38 MAP kinase.
Shetty, R
Moffett, KK
Nguyen, D
Kelly, MJ
Michelotti, EL
Dorsey, BD
Springman, E
Bukhtiyarova, M
Northrop, K
Chai, XM
Saporito, MS
Ochman, AR
Karpusas, M
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
[3] PRAK, a novel protein kinase regulated by the p38 MAP kinase
New, L
Jiang, Y
Zhao, M
Liu, K
Zhu, W
Flood, LJ
Kato, Y
Parry, GCN
Han, JH
EMBO JOURNAL, 1998, 17 (12): : 3372 - 3384
[4] Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds
Dhar, T. G. Murali
Wrobleski, Stephen T.
Lin, Shuqun
Furch, Joseph A.
Nirschl, David S.
Fan, Yi
Todderud, Gordon
Pitt, Sidney
Doweyko, Arthur M.
Sack, John S.
Mathur, Arvind
McKinnon, Murray
Barrish, Joel C.
Dodd, John H.
Schieven, Gary L.
Leftheris, Katerina
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5019 - 5024
[5] Inhibitors of p38α MAP kinase
Chakravarty, S
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 177 - 186
[6] Renal p38 MAP kinase activity in experimental diabetes
Komers, Radko
Lindsley, Jessie N.
Oyama, Terry T.
Cohen, David M.
Anderson, Sharon
LABORATORY INVESTIGATION, 2007, 87 (06) : 548 - 558
[7] Effect of attenuation of p38α or p38β MAP kinase activity on myocardial contractility and ischemic injury
Cross, HR
Murphy, E
Zheng, MZ
Wang, YB
Steenbergen, C
CIRCULATION, 2001, 104 (17) : 101 - 101
[8] PRK, a novel protein kinase regulated by the p38 MAP kinase.
New, T
Jiang, Y
Zhao, M
Liu, K
Flood, L
Kato, Y
Parry, G
Han, J
FASEB JOURNAL, 1998, 12 (04): : A448 - A448
[9] MAP kinase p38 is a novel target of CacyBP/SIP phosphatase
Agnieszka M. Topolska-Woś
Sara Rosińska
Anna Filipek
Amino Acids, 2017, 49 : 1069 - 1076
[10] Inhibition of p38 MAP kinase activity enhances axonal regeneration
Myers, RR
Sekiguchi, Y
Kikuchi, S
Scott, B
Medicherla, S
Protter, A
Campana, WM
EXPERIMENTAL NEUROLOGY, 2003, 184 (02) : 606 - 614

← 1 2 3 4 5 →